These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19069147)

  • 21. Case 6: maintenance therapy for simple intermittent gout.
    Edwards NL
    Am J Med; 2006 Nov; 119(11 Suppl 1):S20-2. PubMed ID: 17059908
    [No Abstract]   [Full Text] [Related]  

  • 22. New-onset diabetes after transplantation: a threat to graft and patient survival.
    Krentz AJ; Wheeler DC
    Lancet; 2005 Feb 19-25; 365(9460):640-2. PubMed ID: 15721460
    [No Abstract]   [Full Text] [Related]  

  • 23. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.
    Sjöström L; Lindroos AK; Peltonen M; Torgerson J; Bouchard C; Carlsson B; Dahlgren S; Larsson B; Narbro K; Sjöström CD; Sullivan M; Wedel H;
    N Engl J Med; 2004 Dec; 351(26):2683-93. PubMed ID: 15616203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding hyperuricemia: nursing implications.
    Johnson ES
    Nurs Clin North Am; 1972 Jun; 7(2):399-406. PubMed ID: 4482424
    [No Abstract]   [Full Text] [Related]  

  • 25. Post-transplant diabetes mellitus and renal function with tacrolimus: A decade of use, a decade of evidence. Foreword.
    Vanrenterghem Y
    Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi1-vi2. PubMed ID: 15575020
    [No Abstract]   [Full Text] [Related]  

  • 26. Risk for posttransplant diabetes mellitus with current immunosuppressive medications.
    Hjelmesaeth J; Hartmann A
    Am J Kidney Dis; 2000 Mar; 35(3):562. PubMed ID: 10692289
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclosporine-induced hyperuricemia and gout in renal transplants.
    Ben Hmida M; Hachicha J; Bahloul Z; Kaddour N; Kharrat M; Jarraya F; Jarraya A
    Transplant Proc; 1995 Oct; 27(5):2722-4. PubMed ID: 7482890
    [No Abstract]   [Full Text] [Related]  

  • 28. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
    Fujimori S
    Nihon Rinsho; 2008 Apr; 66(4):729-35. PubMed ID: 18409523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Idiopathic hyperuricemia with overproduction of uric acid].
    Mizuta E; Igawa O; Hisatome I
    Nihon Rinsho; 2008 Apr; 66(4):675-8. PubMed ID: 18409513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperuricemia in kidney transplant recipients with intact graft function.
    Kim KM; Kim SS; Han DJ; Yang WS; Park JS; Park SK
    Transplant Proc; 2010 Nov; 42(9):3562-7. PubMed ID: 21094816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Over-weight as risk factor with special regard to hypertension, arteriosclerosis and gout].
    Schollmeyer P
    Z Allgemeinmed; 1972 Oct; 48(29):1342-5. PubMed ID: 4636977
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term (24-month) follow-up of steroid withdrawal in renal allograft recipients with posttransplant diabetes mellitus.
    Fabrega AJ; Meslar P; Cohan J; Lash J; Pollak R
    Transplantation; 1995 Dec; 60(12):1612-4. PubMed ID: 8545899
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of the kidney transplant recipient.
    Padiyar A; Akoum FH; Hricik DE
    Prim Care; 2008 Sep; 35(3):433-50, v. PubMed ID: 18710663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New-onset diabetes mellitus after solid organ transplantation.
    Bodziak KA; Hricik DE
    Transpl Int; 2009 May; 22(5):519-30. PubMed ID: 19040489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk profile for cardiovascular morbidity and mortality after lung transplantation.
    De Vito Dabbs A; Song MK
    Nurs Clin North Am; 2008 Mar; 43(1):37-53; vi. PubMed ID: 18249224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gout in renal allograft recipients according to the pretransplant hyperuricemic status.
    Hernández-Molina G; Cachafeiro-Vilar A; Villa AR; Alberú J; Rull-Gabayet M
    Transplantation; 2008 Dec; 86(11):1543-7. PubMed ID: 19077887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New-onset cardiovascular risk factors in lung transplant recipients.
    Silverborn M; Jeppsson A; Mårtensson G; Nilsson F
    J Heart Lung Transplant; 2005 Oct; 24(10):1536-43. PubMed ID: 16210127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview of renal transplantation.
    Hashmi S; Poommipanit N; Kahwaji J; Bunnapradist S
    Minerva Med; 2007 Dec; 98(6):713-29. PubMed ID: 18299684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize risk.
    Liefeldt L; Budde K
    Transpl Int; 2010 Dec; 23(12):1191-204. PubMed ID: 21059108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Refractory hypertension in transplant recipients.
    Tripathi K; Prakash J
    Transplant Proc; 1992 Oct; 24(5):1790. PubMed ID: 1412845
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.